Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

432 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Perceived discrimination in those at clinical high risk for psychosis.
Saleem MM, Stowkowy J, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Addington J. Saleem MM, et al. Among authors: woods sw. Early Interv Psychiatry. 2014 Feb;8(1):77-81. doi: 10.1111/eip.12058. Epub 2013 Jun 17. Early Interv Psychiatry. 2014. PMID: 23773288 Free PMC article.
Treatment of psychosis at onset.
Miller TJ, Woods SW, Rosen JL, McGlashan TH. Miller TJ, et al. Among authors: woods sw. Am J Psychiatry. 2002 Jan;159(1):153. doi: 10.1176/appi.ajp.159.1.153. Am J Psychiatry. 2002. PMID: 11772717 No abstract available.
Prospective observations of emerging psychosis.
Rosen JL, Woods SW, Miller TJ, McGlashan TH. Rosen JL, et al. Among authors: woods sw. J Nerv Ment Dis. 2002 Mar;190(3):133-41. doi: 10.1097/00005053-200203000-00001. J Nerv Ment Dis. 2002. PMID: 11923647
Effects of development on olanzapine-associated adverse events.
Woods SW, Martin A, Spector SG, McGlashan TH. Woods SW, et al. J Am Acad Child Adolesc Psychiatry. 2002 Dec;41(12):1439-46. doi: 10.1097/00004583-200212000-00015. J Am Acad Child Adolesc Psychiatry. 2002. PMID: 12447030
The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. I. Study rationale and design.
McGlashan TH, Zipursky RB, Perkins D, Addington J, Miller TJ, Woods SW, Hawkins KA, Hoffman R, Lindborg S, Tohen M, Breier A. McGlashan TH, et al. Among authors: woods sw. Schizophr Res. 2003 May 1;61(1):7-18. doi: 10.1016/s0920-9964(02)00439-5. Schizophr Res. 2003. PMID: 12648731 Clinical Trial.
The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. II. Baseline characteristics of the "prodromal" sample.
Miller TJ, Zipursky RB, Perkins D, Addington J, Woods SW, Hawkins KA, Hoffman R, Preda A, Epstein I, Addington D, Lindborg S, Marquez E, Tohen M, Breier A, McGlashan TH. Miller TJ, et al. Among authors: woods sw. Schizophr Res. 2003 May 1;61(1):19-30. doi: 10.1016/s0920-9964(02)00440-1. Schizophr Res. 2003. PMID: 12648732 Clinical Trial.
432 results